- Home
- PAAI vs NTRB Comparison
PAAI vs NTRB Comparison
Compare PAAI & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAAI | NTRB |
|---|---|---|
| Founded | 1990 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.8M | 72.6M |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PAAI | NTRB |
|---|---|---|
| Price | $0.73 | $5.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 678.9K | 94.8K |
| Earning Date | 11-12-2026 | 12-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 191.93 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $16,892,000.00 | $2,036,651.00 |
| Revenue This Year | N/A | $4,584.65 |
| Revenue Next Year | $5.00 | $89.09 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 27.46 | N/A |
| 52 Week Low | $0.80 | $2.80 |
| 52 Week High | $3.47 | $9.19 |
Technical Indicators
Market Signals| Indicator | PAAI | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 42.54 | 44.29 |
| Support Level | N/A | $5.70 |
| Resistance Level | $1.90 | $9.19 |
| Average True Range (ATR) | 0.08 | 0.60 |
| MACD | -0.04 | -0.17 |
| Stochastic Oscillator | 2.49 | 11.00 |
Price Performance
Historical ComparisonAbout PAAI Paradium.AI Inc. Common Stock
Paradium.AI Inc is an AI technology company. The group operates as a centralized, AI-optimized infrastructure that puts the tools, data, and reach media entrepreneurs could never build alone directly into their hands. Its products are Infosentience, Encore, and Cutter Studios.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.